DE69929718D1 - Neues regulationssystem zur kontrolle der expression eines transgens - Google Patents

Neues regulationssystem zur kontrolle der expression eines transgens

Info

Publication number
DE69929718D1
DE69929718D1 DE69929718T DE69929718T DE69929718D1 DE 69929718 D1 DE69929718 D1 DE 69929718D1 DE 69929718 T DE69929718 T DE 69929718T DE 69929718 T DE69929718 T DE 69929718T DE 69929718 D1 DE69929718 D1 DE 69929718D1
Authority
DE
Germany
Prior art keywords
controlling
expression
nucleic acid
transgence
regulation system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69929718T
Other languages
English (en)
Other versions
DE69929718T2 (de
Inventor
Jacques Mallet
Olga Corti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9814080A external-priority patent/FR2786198B1/fr
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Application granted granted Critical
Publication of DE69929718D1 publication Critical patent/DE69929718D1/de
Publication of DE69929718T2 publication Critical patent/DE69929718T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/861—Adenoviral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/635—Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Psychology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Mushroom Cultivation (AREA)
  • Surface Acoustic Wave Elements And Circuit Networks Thereof (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Circuit Arrangement For Electric Light Sources In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Video Image Reproduction Devices For Color Tv Systems (AREA)
DE69929718T 1998-11-09 1999-11-09 Neues regulationssystem zur kontrolle der expression eines transgens Expired - Lifetime DE69929718T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR9814080A FR2786198B1 (fr) 1998-11-09 1998-11-09 Nouveau systeme de regulation de l'expression d'un transgene
FR9814080 1998-11-09
US12260099P 1999-03-03 1999-03-03
US122600P 1999-03-03
PCT/FR1999/002752 WO2000028062A1 (fr) 1998-11-09 1999-11-09 Nouveau systeme de regulation de l'expression d'un transgene

Publications (2)

Publication Number Publication Date
DE69929718D1 true DE69929718D1 (de) 2006-04-13
DE69929718T2 DE69929718T2 (de) 2006-11-09

Family

ID=26234639

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69929718T Expired - Lifetime DE69929718T2 (de) 1998-11-09 1999-11-09 Neues regulationssystem zur kontrolle der expression eines transgens

Country Status (11)

Country Link
EP (1) EP1129204B1 (de)
JP (1) JP4516215B2 (de)
KR (1) KR20020013476A (de)
CN (1) CN1352694A (de)
AT (1) ATE317020T1 (de)
AU (1) AU1165400A (de)
CA (1) CA2351015C (de)
DE (1) DE69929718T2 (de)
HU (1) HUP0104032A3 (de)
IL (1) IL142761A0 (de)
WO (1) WO2000028062A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440741B2 (en) * 1999-03-15 2002-08-27 The Trustees Of Columbia University In The City Of New York Expression vector for consistent cellular expression of the tet on repressor in multiple cell types
WO2002086131A1 (fr) * 2001-04-09 2002-10-31 Gencom Corporation Unite de regulation de l'expression genetique et utilisation de cette unite
CN1453361A (zh) * 2003-05-30 2003-11-05 中国科学院上海生命科学研究院 一种抗癌靶向可调控基因－病毒的构建方法
JP2014503173A (ja) * 2009-11-05 2014-02-13 プロイェクト、デ、ビオメディシナ、シーマ、ソシエダッド、リミターダ 制御された発現系
CN102690338A (zh) * 2012-05-25 2012-09-26 中国农业大学 一种与四环素结合的蛋白TetR及其编码基因和应用
CN110358812B (zh) * 2019-06-25 2022-12-27 武汉生物工程学院 一种用于λ-Red重组系统基因敲除重组阳性克隆检测的引物及检测方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09500526A (ja) * 1993-06-14 1997-01-21 ベーアーエスエフ アクツィエンゲゼルシャフト テトラサイクリン反応性プロモーターによる真核細胞の遺伝子発現の厳密な制御
US5965440A (en) * 1995-12-07 1999-10-12 The General Hospital Corporation Controlled gene product delivery from a regulatable retroviral vector
WO1998037185A2 (en) * 1997-02-20 1998-08-27 The Board Of Regents Of The University Of Texas System Vectors for controlled gene expression

Also Published As

Publication number Publication date
CA2351015C (fr) 2011-09-27
IL142761A0 (en) 2002-03-10
KR20020013476A (ko) 2002-02-20
HUP0104032A3 (en) 2003-09-29
EP1129204A1 (de) 2001-09-05
DE69929718T2 (de) 2006-11-09
JP2002529099A (ja) 2002-09-10
CA2351015A1 (fr) 2000-05-18
ATE317020T1 (de) 2006-02-15
JP4516215B2 (ja) 2010-08-04
AU1165400A (en) 2000-05-29
EP1129204B1 (de) 2006-02-01
WO2000028062A1 (fr) 2000-05-18
CN1352694A (zh) 2002-06-05
HUP0104032A2 (hu) 2002-02-28

Similar Documents

Publication Publication Date Title
DE69333731D1 (de) Glialmitogene faktoren, ihre herstellung und verwendung
MX9800419A (es) Haloperoxidasas de curvularia verruculosa y acidos nucleicos que codifican para los mismos.
ATE312190T1 (de) Nukleinsaeure enthaltende zusammensetzungen, herstellung und verwendung
DE69635609D1 (de) Nukleinsäure enthaltende zusammensetzung, herstellung und verwendung
DE69834267D1 (de) Gentherapeutische verfahren zur bereitstellung von apolipoprotein a-i agonisten sowie deren verwendung zur behandlung dyslipidämischer erkrankungen
NZ312332A (en) Recombinational cloning using engineered recombination sites
MY125594A (en) Immortalized cell lines for virus growth
WO1997035990A3 (en) Histone deacetylases, and uses related thereto
ATE175194T1 (de) (e)-20(22)-dehydrovitamin-d-verbindungen
ATE402607T1 (de) Delta-4-desaturase-gene und ihre verwendung
PT851926E (pt) Variantes do interferao-gama (rhu-ifn-gama) recombinante humano com estabilidade termica melhorada
EP1123414A4 (de) Antisense modulation der expression von integrin alpha 4
WO1998020029A3 (en) Hnf3-delta compositions
ATE215135T1 (de) Verfahren zur herstellung von solvens- stabilisierten metallkolloiden und trägerfixierten metallclustern
WO2000030667A3 (en) Compositions and methods using lactadherin or variants thereof
DE69929718D1 (de) Neues regulationssystem zur kontrolle der expression eines transgens
DE60040497D1 (de) Gene, welche für Flavon-Synthasen kodieren
AU1896500A (en) High efficiency mammalian gene expression vectors that contain exogenous promoter and entire 5' untranslated region in the upstream from start codon for inherent gene as transcription regulatory site
KR0140401B1 (en) Anti-bloom triglyceride compositions
HK1038572A1 (en) Growth differentiation factor promoter and uses therefor
MY133666A (en) Enzymatic process for stereoselective preparation of therapeutic amides
WO2000021553A3 (en) Method of regulating smn gene expression
WO1997008934A3 (en) Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors
AUPM772494A0 (en) Improvements in production of proteins in host cells
WO2003070878A3 (en) Antisense modulation of hematopoietic cell protein tyrosine kinase expression

Legal Events

Date Code Title Description
8364 No opposition during term of opposition